Lecture 8 Neurology Theme - Parkinson's Disease and The Motor System Flashcards

1
Q

What is Parkinson’s?

A

A progressive neurodegenerative hypo kinetic disorders characterised by hypo kinetic movement caused by the loss of dopaminergic neurons in the substantia nigra.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the substantia nigra?

A

A midbrain dopaminergic nucleus which modulates motor movement and the reward pathway in the basal ganglia circuitry.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the pathology of PD?

A

Diminished substantia nigra, neuronal loss and Lewy bodies remaining in nerve cells.
Neuromelanin is gone in PD.
50% of cells gone by the time symptoms arise.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

How can we image the substantia nigra terminals?

A

PET
SPECT
MRI
CT
Can see pre-synaptic dopamine in synaptic vessels by 18F-Fluoro-DOPA receptor used in PET scans.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Briefly describe the pathway leading to PD.

A

Dopamine deficiency in the SN means the striatum is less excited and can’t inhibit the globus pallidus through the indirect pathway.
Globus pallidus becomes hyperactive and inhibits the subthalamic nucleus more so there is hyperactivity of the output nuclei and excess inhibition of the motor thalamus.
SN to the striatum is dopaminergic, everything else if GABAergic.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is SNCA gene for and how is it implicated in PD?

A

SNCA gene encodes for alpha synuclein - chromosome 4p21 contains SNCA so a point mutation of gene/polymorphisms of a-synucelin promoter increase the risk of PD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe alpha synucelin in PD.

A

A-synucelin is a normal protein that controls neutotransmitter release.
A-synucelin forms small oligomers which are toxic to neurons and there is evidence to show prion like spread.
The a-synucelin aggregates are hydrophobic and arise in the medulla, ascending through the brainstem to limbic structures and end up in the neocortex.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What gene mutation is associated with late onset PD?

A

LRRK2 - a cytoplasmic kinase so mutations increases kinase activity which leads to PD.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What proteins are associated with PD?

A

Mutations in genes that encode for the proteins DJ-1, PINK-1 and PARKIN.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do PARKIN mutations cause PD?

A

Parkin is a ubiquitin E3 ligase.
It plays a crucial role in ubiquitination where molecules are covalently labelled with ubiquitin and directed towards degradation by proteasome or lysosomes.
Dysfunction in Parkin can lead to dysfunctional ubiquitinisation of dysfunctional molecules and they are then allowed to accumulate.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

How do mutations in DJ-1 cause PD?

A

DJ-1 I s transcriptional regulator and has cytoprotective effects in mitochondria when they come under oxidative stress.
Mutations in DJ-1 cause pathological oxidative stress in mitochondria making them dysfunctional and also contributes to disrupted protein degradation by the proteasome.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

How do mutations in PINK1 cause PD?

A

PINK1 is a kinase that localises to the outer membrane of dysfunctional mitochondria and phosphorylates Parkins (ubiquitin E3 ligases) targets substrates for proteasomal destruction.
If dysfunctional, dysfunctional proteins and mitochondria are not cleared and therefore accumulate.
PINK1 and PARKIN activity rely on each other so dysfunction of either will lead to dysfunctional mitochondrial accumulation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Describe the morphology of PD.

A

Depigmentation of substantial nigra due to loss of dopaminergic neurons not producing dopamine which becomes oxidised to melanin.
Areas of neuronal loss show gliosis causing scars om the brain impacting function (too many or large glial cells to account for the loss of neurons).
Lewy bodies found in remaining neurons.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

How is PD diagnosed?

A

No specific test for diagnosis.
Look for specific symptoms.
Triad of symptoms = bradykinesia, rigidity and tremor.
Additional symptoms may include postural instability, micrographia (small writing) and abnormal gait.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How can a PD diagnosis be best confirmed?

A

Sustained response to L-DOPA replacement therapy.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the different types of PD?

A

Idiopathic
Vascular
Drug-induced
Lewy body dementia

17
Q

What is atypical Parkinsonism?

A

Do not react to L-DOPA and have differential diagnosis due to different symptoms.

18
Q

What is an example of atypical Parkinsonism types?

A

Progressive supra nuclear palsy (PSP).
Tufted astrocytes and presence of tau-containing inclusions in neurons and glia in the brainstem and grey matter and mutations of the tau gene.
Hummingbird sign on imaging helps distinguish between PD and PSP.

19
Q

What is an atypical Parkinsonism sub-type?

A

Corticobasal degeneration (CBD).
Apathy and anhedonia, phantom limb, myoclonus and dystonia seen.
CBD tau lesions are in the cerebral cortex.

20
Q

What are some good diagnostic tests for Parkinsons?

A

CT useful for looking for signs of cerebral ischaemia in suspected vascular PD.
Ioflupane SPECT (DATscan) used to distinguish between idiopathic Parkinson’s and other causes.
In very grey area cases good to look at response to dopaminergic treatment to establish if PD is present.

21
Q

What are some examples of drug treatments for idiopathic PD?

A

L-DOPA
Anticholinergic agents
Catechol-O-methyl transferase (COMT) inhibitors and amantadine used in combination with dopaminergic therapy
Carbidopa
MAO-Bs

22
Q

Describe L-DOPA treatment.

A

Levodopa = precursor to dopamine.
Crosses the BBB where it is converted to dopamine in dopaminergic neurons to boost the supply of dopamine in the cells.
After several years it becomes ineffective as more nerve cells in the SN die so there are fewer to absorb the drug.

23
Q

Why is carbidopa given to PD patients?

A

To prevent LDOPA being broken down before it reaches the brain.

24
Q

Describe MAO-B treatment.

A

MAO-Bs are monoamine oxidase inhibitors so inhibit MOA activity that wrongly ‘vacuums up’ dopamine that is not in use.
Inhibiting this make dopamine more available.

25
Q

Describe surgical treatment for PD.

A

Pallidotomy (GPi) - destroys a little bit of the globes pallidus, reducing brain activities which relieves tremors.
Thalamotomy (Vim) - lesion to the thalamus, disadvantage is it can only be performed on one side of the brain so does not help with bilateral tremors.
Subthalamic nucleus DBS and GPi brain stimulation.